NSE filing, NSE: MASFIN. Summary written from the filing by ALFA Finder's alert engine.
Mas Financial Services Ltd: key numbers
- Share price
- ₹244.65
- Market cap
- ₹4,439 Cr
- Revenue (annual)
- ₹1,995 Cr
- Net profit (annual)
- ₹371.2 Cr
- P/E (TTM)
- 10.6×Sector 19.8×
- Promoter holding
- 66.66%+0.01% QoQ
- FII holding
- 2.67%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Mas Financial Services Ltd
All →Mas Financial Services Earnings Call Transcript: Key Takeaways
MAS Financial continues its consistent growth trajectory, crossing the ₹17,000 crore AUM milestone. Management remains confident in achieving a ₹1 lakh crore AUM by 2036 while maintaining robust asset quality and capital adequacy.
- Call
- Guides 25% growth
Mas Financial Services Investor Presentation: Key Takeaways
Q2FY27: consolidated AUM ₹17,043 Cr (+23.31% YoY), consolidated PAT ₹115 Cr (+25.91% YoY); ROE 15.33%, cost of borrowing 9.19%, MSME-focused lending.
Mas Financial Services Debt & Borrowing
MAS Financial Services confirmed 100% security cover over its secured NCDs as at 30 September 2026. The auditor-certified statement shows cover of 1.11 on book value.
Mas Financial Services Results Update
MAS Financial Services reported Q2 FY27 consolidated PAT of ₹115.12 Crores, up 25.91% YoY, with AUM at ₹17,042.86 Crores. Standalone PAT was ₹110.05 Crores on ~23% growth.
Mas Financial Services Q2 FY27 Results: Net Profit ₹115.1 Cr, Up 25.9% YoY
Mas Financial Services Ltd reported revenue from operations of ₹589.4 Cr (+22.7% YoY) and net profit of ₹115.1 Cr (+25.9% YoY) for Q2 FY27.
- Key figure
- Net profit ₹115.1 Cr · +25.9% YoY
Mas Financial Services Board Meeting Date
MAS Financial Services has scheduled a board meeting for October 28, 2026, to consider financial results for the quarter and half-year ended September 30, 2026.
Other fund raise announcements
All →Rite Zone Chemcon India Fund Raise of ₹6.58 Cr
Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.
- Value
- ₹6.58 Cr
Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.